MedPath

VABYSMO

VABYSMO

Approved
DIN Number

02554003

Drug Class

Human

Market Date

N/A

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02554003
AIG Number0163722001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
S01LA09 FARICIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravitreal
AHFS Classification52:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

FARICIMABActive
Strength: 6 MG / 0.05 ML
Monograph: FARICIMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.